|
|
|
|
|
| July 9,
2010 | ISSUE NUMBER 156 VOL 8 |
Strategy
Merck to Close Eight Plants
As part of its plan to save $3.5 billion by 2012, Merck announced on Thursday the “phasing out” of eight manufacturing sites, as well as eight research sites.
Advertisement:
Are You Really Closing the Loop?
There is a considerable advantage to being one of the first companies in pharma to successfully close the loop and pave the way to a new commercial model that puts the customer first. However, implementing comprehensive, closed-loop marketing has proven difficult for many in our industry. Capgemini Consulting examines the functional implications for implementing closed-loop marketing across the commercial organization and the hurdles to overcome to fully close the loop.
 Click here
|
Global
Response to the Fiscal Crisis: The Valuing Conversation
As Europe sets the pace in slashing drug prices to meet austerity goals industry is seeking fresh ways to control the fallout. Will more dialogue be enough?
People
Berwick Appointed Head of CMS
With a long, hard fight looming, President Obama decided to go around Congress to install Don Berwick, founder of the Institute for Healthcare Improvement, as the top administrator of the Centers for Medicaid and Medicare Services.
R&D
HIV Market Banking on Fixed-Dose Treatments
With the looming patent expiration of many high-profile HIV cocktail treatments, pharma is going to see a deep decline in sales. Will single-dose HIV treatments be the answer?
In the Magazine
Crackdown on the C-Suite
Lewis Morris, top lawyer in HHS's office of inspector general, explains his new move to target pharma execs for serious and ongoing healthcare fraud.
|
| 
|
 Jiangbo Pharmaceuticals appointed Linxian Jin its new CEO.
// Questcor Pharmaceuticals added Mitchell Blutt to its board.
// Biostar Pharmaceuticals hired Deyin Chen as CFO.
// Novavax made Gregory Glenn its new CSO.
// Tengion appointed Sunita Sheth chief medical officer and vice president of clinical and regulatory affairs.
// K-V Pharmaceutical elected David Sidransky to its board.
|
|
|
Jul 26–27 Bio/Pharmaceutical Summit: Optimize Market Research and to Drive Accurate Product Forecasts
Philadelphia, PA
Jul 29–30 5th Annual Congress on Clinical Supply Chain Management
Princeton, NJ
Sep 9–10 Clinical Trials in Latin America
Lima, Peru
Sep 29–30 6th Annual Bio/Pharmaceutical and Medical Device Product Recalls Summit
Washington, DC
Dec 8—9 CMAC 2010 - Commercialization and Market Access Congress
Orlando, FL
|
|
|
|
 |
|
 |
|
 |
| If you plan to enter emerging markets over the next 3 years, what will be your primary entry strategy? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
